Table 1.

Physician Survey: 4 NVL Aspects used to assess Difficulty of Implementation and Impact on Treatment Success (excerpt from survey questionnaire).

Monitoring Adherence	At least once per year documentation of medical history, laboratory values, physical and technical examinations (includes weight, blood pressure, peripheral arteries, eye and foot examinations, examinations of the peripheral nervous system, examination of the injection sites in insulin-treated people with diabetes).
Screening Adherence	Annual screening for secondary and concomitant diseases of T2DM: diabetic neuropathy, foot lesions, nephropathy, retinal complications, macrovascular and microvascular risk assessment, an examination of a depressive disorder.
Targeting Adherence	Agreement of individual treatment targets with the patient for lifestyle, glycemic control (blood glucose, HbA1c), LDL cholesterol, weight, and blood pressure.
Therapy Adherence	Adherence to the treatment algorithm “Grundzuege der Behandlung des Typ-2-Diabetes” (basic principles of treatment for type 2 diabetes): If the individual HbA1C treatment target is not reached, diabetes therapy is escalated every 3–6 months from stage 1 (basic therapy) to stage 4 (intensified insulin and combination therapy).